GlobalData sees new biopsy device boosting India’s bone cancer treatment market | Healthcare Asia Magazine
, India
109 views
Photo by Marcelo Leal on Unsplash

GlobalData sees new biopsy device boosting India’s bone cancer treatment market

The newly patented device simplifies tissue extraction in a bone marrow biopsy.

A recently patented bone marrow biopsy device developed by a group of medical professionals in India could help boost the country’s bone cancer treatment market, according to data analytics firm GlobalData.

Doctors and faculty members from Gujrat Cancer Research Institute (GCRI) and the Institute of Infrastructure Technology Research and Management (IITRAM) designed a new tool that simplifies the process of tissue extraction during a bone marrow biopsy. 

“The introduction of a new bone marrow biopsy device is expected to yield positive implications for medical diagnosis in India,” GlobalData medical devices analyst Ayshi Ganguly said in a statement. 

The country’s biopsy needle devices, which make up for nearly 12% of the entire Asia Pacific market this year, is projected to grow at a compound annual growth rate of nearly 3% through 2030 based on a research by the firm. 

“The device has the potential to disrupt the Indian bone marrow biopsy market as it scores over conventional biopsy needles and will eventually boost the bone cancer diagnosis ecosystem in India,” Ganguly added.

Bone marrow biopsy involves extraction of a bone marrow sample for testing which is vital in determining the proper treatment for a cancer patient.

The device, granted with an Indian patent, comes with three indicators that can identify the bone, confirm if the tool was successfully inserted into the bone, and give an alert in case there was bone perforation, where a hole is pierced through the opposite end.

With the aid of additional depth sensors and pressure control technology, it also offers a more accurate and efficient extraction compared to manual or electronic needles.

Ganguly said the new device may reduce the risks brought about by traditional needle biopsies like infections, nerve and blood vessel damage as well as uncontrolled bleeding. She said it can also help avoid accidental damage to tissues and bones.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Hong Kong seeks prescription for nursing shortage
The city must improve working conditions and offer nurses better pay.
Healthcare
Outpatient care eases pressure on Singapore hospitals
Hospitalisation is more expensive due to room charges, nursing care, and other fees.
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.